MediFind found 14856 doctor with experience in Late-Onset Retinal Degeneration near The United States. Of these, 8392 are Experienced, 4579 are Advanced, 1755 are Distinguished and 130 are Elite.
Duke Eye Center
Glenn Jaffe is an Ophthalmologist and a General Surgeon in Durham, North Carolina. Dr. Jaffe is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Jaffe is currently accepting new patients.
Vitreous Retina Macula Consultants Of New York(Downtown)
Richard Spaide is an Ophthalmologist in New York, New York. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.
Duke Eye Center
Dilraj Grewal is an Ophthalmologist and a General Surgeon in Durham, North Carolina. Dr. Grewal is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Uveitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Cataract Removal, and Vitrectomy. Dr. Grewal is currently accepting new patients.
Duke Eye Center Arringdon
Eleonora Lad is an Ophthalmologist in Morrisville, North Carolina. Dr. Lad is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Geographic Atrophy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Central Serous Chorioretinopathy. Dr. Lad is currently accepting new patients.
State University Of Iowa
Ian Han is an Ophthalmologist in Iowa City, Iowa. Dr. Han has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinitis Pigmentosa, Cataract Removal, and Vitrectomy. Dr. Han is currently accepting new patients.
University Of North Carolina At Chapel Hill
Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), and Usher Syndrome Type 2A. Dr. Iannaccone is currently accepting new patients.
Texas Retina Associates
Ashkan Abbey is an Ophthalmologist in Rockwall, Texas. Dr. Abbey has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.
Northern California Retina Vitreous Associates
Rahul Khurana is an Ophthalmologist in Mountain View, California. Dr. Khurana is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Uveitis, and Vitrectomy.
Cleveland Clinic Main Campus
Peter Kaiser is an Ophthalmologist in Cleveland, Ohio. Dr. Kaiser has been practicing medicine for over 38 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Osteotomy.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
The Johns Hopkins Hospital
Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.
Allen Ho is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Ho is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Ho is currently accepting new patients.
Massachusetts Eye And Ear Associates, Inc
John Miller is an Ophthalmologist in Boston, Massachusetts. Dr. Miller has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy. Dr. Miller is currently accepting new patients.
County Of Santa Clara
Diana Do is an Ophthalmologist in San Jose, California. Dr. Do is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.
UPMC Vision Institute
Jose' Sahel is an Ophthalmologist in Pittsburgh, Pennsylvania. Dr. Sahel is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, X-Linked Congenital Stationary Night Blindness, Cone-Rod Dystrophy, Retinitis Pigmentosa, and Vitrectomy. Dr. Sahel is currently accepting new patients.
Regents Of The University Of California
William Freeman is an Ophthalmologist in San Diego, California. Dr. Freeman is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Macular Edema (DME), and Vitrectomy.
University Of Miami
Stephen Schwartz is an Ophthalmologist in Miami, Florida. Dr. Schwartz is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Endophthalmitis, Vitrectomy, and Cataract Removal. Dr. Schwartz is currently accepting new patients.
Retina Vitreous Associates Of FL
David Eichenbaum is an Ophthalmologist in St Petersburg, Florida. Dr. Eichenbaum is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Macular Edema (DME), and Vitrectomy.
University Retina & Macula Associates, PC
Veeral Sheth is an Ophthalmologist in Oak Forest, Illinois. Dr. Sheth is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Diabetic Macular Edema (DME), and Vitrectomy.
The Johns Hopkins Hospital
Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.
Last Updated: 01/09/2026














